Skip to main content

Affinity Asset Advisors, LLC

Source: SEC Form 13F · as of Mar 2026

Affinity Asset Advisors, LLC holds 49 biotech & pharma companies tracked by BioSniper, totaling $1.06B in value as of Mar 2026 (SEC Form 13F).

Companies held

49

Total value held

$1.06B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Apogee Therapeutics, Inc. (APGE)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
APGEApogee Therapeutics, Inc.1,284,926$108.2M
INSMINSMED Inc480,000$78.5M
ROIVRoivant Sciences Ltd.2,800,000$77.6M
SYRESpyre Therapeutics, Inc.1,279,134$64.5M
CNTACentessa Pharmaceuticals plc1,400,000$55.6M
ANABANAPTYSBIO, INC940,000$52.1M
CYTKCYTOKINETICS INC700,483$46.2M
ABVXAbivax SA405,000$45.1M
TEVATeva Pharmaceutical Industries Limited1,400,000$42.2M
NUVLNuvalent, Inc.300,000$30.7M
TERNTerns Pharmaceuticals, Inc.562,631$29.7M
DNTHDianthus Therapeutics, Inc. /DE/350,000$29.4M
COGTCogent Biosciences, Inc.750,000$28.9M
STROSUTRO BIOPHARMA, INC.1,069,519$26.6M
FBRXForte Biosciences, Inc.1,011,890$26.2M
ORKAOruka Therapeutics, Inc.499,673$24.5M
OVIDOvid Therapeutics Inc.10,636,318$23.6M
ELVNEnliven Therapeutics, Inc.586,904$23.0M
AVTXAvalo Therapeutics, Inc.1,340,840$20.0M
PTGXProtagonist Therapeutics, Inc172,125$18.1M
CLDXCelldex Therapeutics, Inc.500,000$15.9M
ZURAZura Bio Ltd2,564,303$15.3M
NRIXNurix Therapeutics, Inc.967,620$15.0M
SVRASavara Inc2,512,153$13.7M
CATXPerspective Therapeutics, Inc.3,164,582$13.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.200,000$12.5M
DMRADamora Therapeutics, Inc.450,000$11.7M
BBIOBridgeBio Pharma, Inc.150,000$11.1M
CGEMCullinan Therapeutics, Inc.781,260$11.1M
RVMDREVOLUTION MEDICINES, INC.100,000$9.7M
JBIOJade Biosciences, Inc.639,956$9.0M
TVTXTravere Therapeutics, Inc.300,000$8.9M
NAMSNEWAMSTERDAM PHARMA CO N.V.275,000$8.8M
KRROKorro Bio, Inc.706,904$8.0M
CMPSCOMPASS Pathways plc1,108,483$6.1M
VRDNViridian Therapeutics, Inc.\DE250,000$4.9M
CLYMClimb Bio, Inc.700,000$4.8M
RZLTRezolute, Inc.1,547,641$4.7M
SGMTSagimet Biosciences Inc.868,020$4.5M
MANEVeradermics Incorporated70,000$4.4M
RLAYRelay Therapeutics, Inc.400,000$4.0M
PRQRProQR Therapeutics N.V.2,454,278$4.0M
IMVTImmunovant, Inc.100,000$2.5M
SABSSAB BIOTHERAPEUTICS, INC.575,000$2.2M
KZRKezar Life Sciences, Inc.229,076$1.7M
ALECAlector, Inc.500,000$1.1M
OKUROnKure Therapeutics, Inc.240,963$998K
LENZLENZ Therapeutics, Inc.100,000$915K
XFORX4 Pharmaceuticals, Inc145,000$599K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.